John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), sold 38,632 shares at $0.81 ($31K) on 2023-02-27, disclosed to the SEC on 2023-03-01.
Seasonal sale ($31k) by CEO and President — this insider has traded AKBA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |